Roth M, Giraldo P, Hariti G, Poloni E S, Sanchez-Mazas A, Stefano G F, Dugoujon J M, Coppin H
CNRS UPR 8291, CHU Purpan, 31300 Toulouse, France.
Immunogenetics. 1997;46(3):222-5. doi: 10.1007/s002510050265.
A Celtic origin for hemochromatosis, a common genetic iron metabolism disorder, has been postulated for a long time. To check whether the two mutations recently identified in the HLA-class I candidate gene for this disease were found only in Caucasians, we examined their frequencies in individuals originating from Algeria, Ethiopia, and Senegal. The presumably disease-causing mutation, responsible for the Cys282Tyr substitution, was not found in any member of these ethnic groups, although it was shown to be highly prevalent in populations of European ancestry. This geographic distribution supports the previously suggested Celtic origin for the disease. In contrast, the mutation responsible for the His63Asp substitution is not restricted to European populations. Although absent in the Senegalese, it was found on about 9% of the chromosomes of the Central Ethiopians and Algerians (Mzab) genotyped for this study. This second mutation, which probably represents a common variant unrelated to hemochromatosis, thus appears to have occurred earlier than that responsible for the Cys282Tyr substitution. More detailed population studies are needed to provide information on the age of these two mutations and eventually show how the hemochromatosis-causing mutation chronologically spread throughout Europe.
长期以来,人们一直推测常见的遗传性铁代谢紊乱疾病——血色素沉着症起源于凯尔特人。为了验证最近在该疾病的HLA - I类候选基因中发现的两种突变是否仅在高加索人中出现,我们检测了来自阿尔及利亚、埃塞俄比亚和塞内加尔人群中这些突变的频率。尽管在欧洲血统人群中显示该突变高度流行,但在这些种族群体的任何成员中均未发现推测导致疾病的、引起半胱氨酸282到酪氨酸替换的突变。这种地理分布支持了先前提出的该疾病起源于凯尔特人的观点。相比之下,导致组氨酸63到天冬氨酸替换的突变并不局限于欧洲人群。虽然在塞内加尔人群中未发现,但在本研究进行基因分型的埃塞俄比亚中部人群和阿尔及利亚(姆扎卜)人群中,约9%的染色体上发现了该突变。因此,这第二种突变可能代表了一种与血色素沉着症无关的常见变异,其出现时间似乎早于导致半胱氨酸282到酪氨酸替换的突变。需要更详细的人群研究来提供这两种突变出现时间的信息,并最终揭示导致血色素沉着症的突变在时间上是如何在欧洲传播的。